{
    "title": "U.S. FDA approves TG Therapeutics' multiple sclerosis drug; shares surge",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11580109/U-S-FDA-approves-TG-Therapeutics-multiple-sclerosis-drug.html",
    "date": "2022-12-28",
    "keywords": [
        "drug",
        "approval",
        "roy",
        "khushi",
        "mandowara",
        "health",
        "sclerosis",
        "year",
        "disease",
        "wednesday",
        "regulator",
        "antibody",
        "afternoon",
        "trade",
        "food",
        "administration",
        "fda",
        "number",
        "disorder",
        "blow",
        "companys",
        "withdrawal",
        "cancer",
        "tg",
        "briumvi",
        "quarter",
        "pricing",
        "analyst",
        "howerton",
        "range",
        "patient",
        "comparison",
        "list",
        "price",
        "immune",
        "system",
        "brain",
        "motor",
        "institutes",
        "ms",
        "class",
        "role",
        "inflammation",
        "warning",
        "infusion",
        "latestage",
        "study",
        "relapse",
        "company",
        "high",
        "reporting",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "anil",
        "dsilva",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}